RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$870M
AUM Growth
-$103M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
104
New
Increased
Reduced
Closed

Top Buys

1 +$23M
2 +$19.8M
3 +$11.2M
4
MOH icon
Molina Healthcare
MOH
+$11.2M
5
DXCM icon
DexCom
DXCM
+$10.6M

Top Sells

1 +$21.9M
2 +$21.4M
3 +$16.5M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$14.7M
5
BSX icon
Boston Scientific
BSX
+$14.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIR icon
76
Vir Biotechnology
VIR
$896M
$1.3M 0.15%
+200,000
ALKS icon
77
Alkermes
ALKS
$5.08B
$1.29M 0.15%
39,000
-38,999
KURA icon
78
Kura Oncology
KURA
$937M
$1.29M 0.15%
195,000
-119,526
ARVN icon
79
Arvinas
ARVN
$698M
$1.28M 0.15%
183,000
+27,500
AMGN icon
80
Amgen
AMGN
$156B
$1.25M 0.14%
4,000
+1,000
GERN icon
81
Geron
GERN
$804M
$1.24M 0.14%
783,000
-217,000
ICLR icon
82
Icon
ICLR
$13.6B
$1.22M 0.14%
+7,000
GPCR icon
83
Structure Therapeutics
GPCR
$1.65B
$1.21M 0.14%
+70,000
RLAY icon
84
Relay Therapeutics
RLAY
$1.3B
$1.21M 0.14%
460,000
XENE icon
85
Xenon Pharmaceuticals
XENE
$3.28B
$1.17M 0.14%
35,000
MEDP icon
86
Medpace
MEDP
$16.3B
$1.16M 0.13%
3,800
-3,000
ANNX icon
87
Annexon
ANNX
$387M
$888K 0.1%
460,000
-82,500
IMCR icon
88
Immunocore
IMCR
$1.71B
$839K 0.1%
28,278
-30,000
AVTR icon
89
Avantor
AVTR
$10.2B
$775K 0.09%
47,826
-14,000
IDYA icon
90
IDEAYA Biosciences
IDYA
$2.91B
$647K 0.07%
39,500
-42,500
APLS icon
91
Apellis Pharmaceuticals
APLS
$3.78B
$618K 0.07%
28,250
-167,341
PEN icon
92
Penumbra
PEN
$9.28B
$588K 0.07%
+2,200
RGEN icon
93
Repligen
RGEN
$8.66B
$573K 0.07%
4,500
-4,500
IMVT icon
94
Immunovant
IMVT
$3.79B
$443K 0.05%
25,924
-119,076
ACHC icon
95
Acadia Healthcare
ACHC
$2.12B
-13,750
CRL icon
96
Charles River Laboratories
CRL
$9.27B
-14,850
IGMS
97
DELISTED
IGM Biosciences
IGMS
-126,064
NVO icon
98
Novo Nordisk
NVO
$231B
-50,000
PLRX icon
99
Pliant Therapeutics
PLRX
$112M
-116,250
SYK icon
100
Stryker
SYK
$144B
-22,500